Branch TIBS 23: 45-50, Feb. 1998.* |
Toulme et al., Ann. Parasitol. Comp. (France), vol. 65, Suppl. 1, pp. 11-14, 1990.* |
Maher et al., Archives Biochem. and Biophys. 253 (1) pp. 214-220, 1987.* |
Wu et al., Cell Growth and Differentiation, 4(2). pp. 115-123, 1993.* |
Inagaki et al., Annals of the New York Academy of Sciences, vol. 660., pp. 315-317, 1992.* |
Behl et al., Proc. Am. Assoc. Cancer Res. Annu. Meet. 32 (0), p. 427, 1991.* |
Jachimczak et al., Proc. Am. Assoc. Cancer Res. Annu. Meet. 32 (0), p. 248, 1991.* |
Potts et al., PNAS 88(4). pp. 1516-1520, 1991.* |
Wu et al. J. Cell. Biol. 116 (1). pp. 187-196, Jan. 1992.* |
Potts et al. J. Cell. Biol. 111. (5 part 2), 239A, 1990.* |
Inagaki et al., Transplant. Proceed. Dec. 24 (6). pp. 2971-2972, 1992.* |
Stull et al. Pharm. Res. 12(4). pp. 465-483, 1990.* |
Bogdahn, et al., “Autocrine stimulation of malignant gliomas in vitro by TGF-β: A study with phosphorothioate antisense oligonucleotides,” Proceedings of Annual Meeting of the American Association for Cancer Research, 34, 518(1993), Abstract, ISSN: 0197-016X [XP-002137611 (3091)]. |
Chai et al., “Specific transforming growth factor-β subtypes regulate embryonic mouse Meckel's cartilage and Tooth development,” Development Biology, 162, 85-103 (1994) [XP-000907143]. |
Tanaka et al., “Synthesis of oligoribonucleotides via the Phosphite-triester approach on a polymer support,” Chem. Pharm. Bull., 34, 1426-1432 (1986) [XP-002058337]. |
Jachimczak, et al., “The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma,” J. Neurosurg, 78, 944-951 (Jun. 1993) [XP-000886109]. |